People news: Bexion, OraSure Technologies, Ziopharm Oncology

Share this article:

Former FDA commissioner Dr. Lester Crawford, who has worked at a Washington lobbying firm since resigning from the agency in 2005, joined the board of Bexion Pharmaceuticals. Confirmed as commissioner in July 2005, Crawford suddenly resigned from the agency just two months into the role. He later pleaded guilty to lying and violating conflict-of-interest laws.

Device firm OraSure Technologies hired Tony Zezzo as EVP of marketing and sales. He has almost 30 years experience in the diagnostics industry, most recently as VP, North America sales and marketing, Ortho-Clinical Diagnostics.

Ziopharm Oncology hired Dr. Mark Thornton as VP, chief development officer. He is returning to the company after a stint as medical officer for the FDA's Center for Biologics Evaluation and Research.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media